Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Virulence ; 9(1): 898-918, 2018 12 31.
Article in English | MEDLINE | ID: mdl-29638186

ABSTRACT

Helicobacter suis colonizes the stomach of most pigs and is the most prevalent non-Helicobacter pylori Helicobacter species found in the human stomach. In the human host, H. suis contributes to the development of chronic gastritis, peptic ulcer disease and MALT lymphoma, whereas in pigs it is associated with gastritis, decreased growth and ulcers. Here, we demonstrate that the level of H. pylori and H. suis binding to human and pig gastric mucins varies between individuals with species dependent specificity. The binding optimum of H. pylori is at neutral pH whereas that of H. suis has an acidic pH optimum, and the mucins that H. pylori bind to are different than those that H. suis bind to. Mass spectrometric analysis of mucin O-glycans from the porcine mucin showed that individual variation in binding is reflected by a difference in glycosylation; of 109 oligosaccharide structures identified, only 14 were present in all examined samples. H. suis binding to mucins correlated with glycans containing sulfate, sialic acid and terminal galactose. Among the glycolipids present in pig stomach, binding to lactotetraosylceramide (Galß3GlcNAcß3Galß4Glcß1Cer) was identified, and adhesion to Galß3GlcNAcß3Galß4Glc at both acidic and neutral pH was confirmed using other glycoconjugates. Together with that H. suis bound to DNA (used as a proxy for acidic charge), we conclude that H. suis has two binding modes: one to glycans terminating with Galß3GlcNAc, and one to negatively charged structures. Identification of the glycan structures H. suis interacts with can contribute to development of therapeutic strategies alternative to antibiotics.


Subject(s)
Gastric Mucins/metabolism , Glycolipids/metabolism , Helicobacter Infections/microbiology , Helicobacter Infections/veterinary , Helicobacter heilmannii/metabolism , Polysaccharides/metabolism , Swine Diseases/metabolism , Animals , Gastric Mucosa/metabolism , Glycosylation , Helicobacter Infections/metabolism , Helicobacter heilmannii/genetics , Humans , Stomach/microbiology , Swine , Swine Diseases/microbiology
2.
Sci Rep ; 7(1): 1430, 2017 05 03.
Article in English | MEDLINE | ID: mdl-28469147

ABSTRACT

Filamentous bulking caused by Thiothrix species is responsible for sludge washout and loss of performance in dairy wastewater treatment plants. A long-term study was conducted over 1.5 years to test three different mitigation strategies in a full-scale plant composed of two parallel sequential batch reactors (SBR1 and 2). Strategies based on polyaluminium chloride addition and volatile fatty acids reduction were ineffective to permanently solve the problem. On the contrary, modification of the reactor cycle based on the implementation of a periodic starvation proved efficient to solve the biomass wash-out and drastically reduce the sludge volume index in both reactors. Bacterial diversity analysis using 16S amplicon sequencing and quantitative PCR indicated a reduction of Thiothrix abundance from 51.9 to 1.0% in SBR1 and from 71.8 to 0.6% in SBR2. Simultaneously, the abundance of the glycogen-accumulating bacterium Candidatus Competibacter increased in both reactors. Microscopy analysis confirmed the transition between a bulking sludge towards a granular-like sludge. This study confirms the applicability of a periodic starvation to (1) solve recurring Thiothrix bulking, (2) convert loose aggregates into dense and compact granular-like structures and (3) considerably reduce energy demand for aeration.


Subject(s)
Batch Cell Culture Techniques/methods , Sewage/chemistry , Thiothrix/metabolism , Waste Disposal, Fluid/methods , Aluminum Hydroxide/pharmacology , Animals , Bioreactors , Cattle , Dairying , Fatty Acids, Volatile/pharmacology , Glycogen/metabolism , Helicobacter heilmannii/drug effects , Helicobacter heilmannii/growth & development , Helicobacter heilmannii/metabolism , Humans , Microbial Consortia/drug effects , Microbial Consortia/physiology , RNA, Ribosomal, 16S/genetics , Thiothrix/drug effects , Thiothrix/genetics , Thiothrix/growth & development
3.
Int J Syst Evol Microbiol ; 62(Pt 2): 299-306, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21421932

ABSTRACT

Three gram-negative, microaerophilic bacteria, strains ASB1(T), ASB2 and ASB3, with a corkscrew-like morphology isolated from the gastric mucosa of cats were studied using a polyphasic taxonomic approach. The isolates grew on biphasic culture plates under microaerobic conditions at 37 °C and exhibited urease, oxidase and catalase activities. They were also able to grow in colonies on dry agar plates. Based on 16S rRNA gene sequence analysis, ASB1(T), ASB2 and ASB3 were identified as members of the genus Helicobacter and showed 98 to 99 % sequence similarity to strains of Helicobacter felis, Helicobacter bizzozeronii, 'Candidatus Helicobacter heilmannii', Helicobacter cynogastricus, Helicobacter baculiformis and Helicobacter salomonis, six related Helicobacter species previously detected in feline or canine gastric mucosa. Sequencing of the partial hsp60 gene demonstrated that ASB1(T), ASB2 and ASB3 constitute a separate taxon among the feline and canine Helicobacter species. The urease gene sequences of ASB1(T), ASB2 and ASB3 showed approximately 91 % similarity to those of 'Candidatus Helicobacter heilmannii'. Protein profiling, the absence of alkaline phosphatase activity and several other biochemical characteristics also allowed strains ASB1(T), ASB2 and ASB3 to be differentiated from other Helicobacter species of feline or canine gastric origin. The results of this polyphasic taxonomic study show that the cultured isolates constitute a new taxon corresponding to 'Candidatus Helicobacter heilmannii', which was previously demonstrated in the stomach of humans, wild felidae, cats and dogs. The name Helicobacter heilmannii sp. nov. is proposed for these isolates; the type strain is ASB1(T) (=DSM 24751 (T) =LMG 26292(T)) [corrected].


Subject(s)
Cat Diseases/microbiology , Gastric Mucosa/microbiology , Helicobacter Infections/veterinary , Helicobacter heilmannii/classification , Helicobacter heilmannii/isolation & purification , Animals , Bacterial Proteins/chemistry , Bacterial Typing Techniques , Cats , Chaperonin 60/genetics , Chaperonin 60/metabolism , DNA, Bacterial/analysis , DNA, Ribosomal/analysis , Dogs , Electrophoresis/methods , Genes, rRNA , Helicobacter Infections/microbiology , Helicobacter heilmannii/genetics , Helicobacter heilmannii/metabolism , Humans , Molecular Sequence Data , Phylogeny , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Species Specificity , Urease/genetics
4.
Vaccine ; 24(14): 2469-76, 2006 Mar 24.
Article in English | MEDLINE | ID: mdl-16423431

ABSTRACT

"Helicobacter (H.) heilmannii" type 1 colonizes the human stomach. It has been shown to be identical to "Candidatus H. suis", a Helicobacter species colonizing the stomach of more than 60% of slaughter pigs. This bacterium is, until now, not isolated in vitro. The effect of vaccination on "Candidatus H. suis" infection was studied in a mouse model. Mice were vaccinated intranasally or subcutaneously with whole bacterial cell lysate of Helicobacter pylori or Helicobacter felis and subsequently challenge infected with "Candidatus H. suis". Intranasal and subcutaneous immunisation caused a decrease in faecal excretion of "Candidatus H. suis" DNA. Urease tests on stomach tissue samples at 16 weeks after challenge infection were negative in all H. felis intranasally immunized animals and in the majority of the animals of the other immunisation groups. Since PCR on stomach tissue samples at 16 weeks after challenge infection could still detect "Candidatus H. suis DNA" in all immunisation-challenge groups, complete clearance of challenge bacteria was not achieved.


Subject(s)
Antigens, Heterophile/administration & dosage , Bacterial Vaccines/administration & dosage , Helicobacter Infections/prevention & control , Helicobacter felis/chemistry , Helicobacter heilmannii/drug effects , Helicobacter pylori/chemistry , Administration, Intranasal , Animals , Antigens, Bacterial/administration & dosage , Antigens, Bacterial/immunology , Antigens, Heterophile/immunology , Bacterial Vaccines/immunology , DNA, Bacterial/analysis , Helicobacter heilmannii/metabolism , Immunization , Injections, Subcutaneous , Mice , Mice, Inbred BALB C , Polymerase Chain Reaction
5.
Dig Dis Sci ; 47(4): 823-30, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11991617

ABSTRACT

We evaluated some aspects of the immune response to Helicobacter heilmannii in two mouse strains. Gastritis that was more severe in infected C57BL/6 mice. A proliferative response to H. pylori antigens was observed in splenocytes from H. heilmannii-positive and -negative mice, similar in the positive- and negative-BALB/c mice, but lower in the positive- than in the negative-C57BL/6 animals. A decrease in B cells and an increase in CD4+ cells after stimulation with type I H. pylori antigen and an increase in CD8+ cells after stimulation with type I and II antigens was observed in infected C57BL/6 mice. Conversely, the percentage of CD4+, CD8+, and B cells was similar in positive- and negative-BALB/c mice. These results demonstrated that the immune response is similar in H. heilmannii and H. pylori infection and strengthened the importance of host and bacterial virulence markers in the immune response to gastric Helicobacter infections.


Subject(s)
Helicobacter Infections/immunology , Helicobacter heilmannii , Immunity, Cellular , Animals , Antigens, Bacterial/analysis , Antigens, Bacterial/pharmacology , B-Lymphocytes/pathology , Bacterial Proteins/metabolism , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/pathology , Cell Division/drug effects , Cells, Cultured , Female , Gastritis/microbiology , Helicobacter Infections/pathology , Helicobacter heilmannii/metabolism , Helicobacter heilmannii/pathogenicity , Helicobacter pylori/immunology , Helicobacter pylori/metabolism , Helicobacter pylori/pathogenicity , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Species Specificity , Spleen/microbiology , Spleen/pathology
6.
J Clin Microbiol ; 37(4): 1069-76, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10074528

ABSTRACT

Spiral organisms were isolated from an antral gastric mucosal biopsy specimen from a dyspeptic patient with gastritis. Only corkscrew-shaped organisms resembling "Gastrospirillum hominis" ("Helicobacter heilmannii") but no Helicobacter pylori-like organisms were seen in histological sections. H. pylori was not cultured from specimens from this patient. On the basis of biochemical reactions, morphology, ultrastructure, and 16S DNA sequencing, the isolated "G. hominis" was shown to be a true Helicobacter sp. very similar to Helicobacter felis and the "Gastrospirillum" but was separate from H. pylori. "G. hominis" is a pleomorphic gram-negative cork-screw-shaped, motile rod with 3 to 8 coils and a wavelength of about 1 micrometer. In contrast to H. pylori, it has up to 14 sheathed flagellar uni- or bipolar fibrils but no periplasmic fibrils. "G. hominis" grows under microaerobic conditions at 36 and 41 degrees C on 7% lysed, defibrinated horse blood agar plates within 3 to 7 days and can be subcultured under microaerobic but not under anaerobic conditions on media similar to those used for H. pylori and H. felis. The small translucent colonies were, in contrast to those of H. felis, indistinguishable from those of H. pylori. "G. hominis" is, like H. pylori and H. felis, motile, is oxidase, catalase, nitrite, nitrate, and urease positive, and produces alkaline phosphatase and arginine arylamidase. Like H. pylori and H. felis, it is sensitive to cephalothin (30-microgram disc), resistant to nalidixic acid (30-microgram disc), and sensitive to most other antibiotics. The 16S DNA sequence clusters "G. hominis" together with "Gastrospirillum," H. felis, Helicobacter bizzozeronii, Helicobacter salmonii, Helicobacter nemestrinae, Helicobacter acinonychis, and H. pylori.


Subject(s)
Bacterial Infections/microbiology , Gastric Mucosa/microbiology , Gastritis/microbiology , Helicobacter heilmannii/isolation & purification , Helicobacter/isolation & purification , Adult , Bacterial Proteins/chemistry , Base Sequence , DNA Primers/genetics , DNA, Bacterial/genetics , DNA, Ribosomal/genetics , Drug Resistance, Microbial , Helicobacter/metabolism , Helicobacter/ultrastructure , Helicobacter heilmannii/metabolism , Helicobacter heilmannii/ultrastructure , Humans , Male , Microscopy, Electron , Phylogeny , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...